114 related articles for article (PubMed ID: 9478297)
1. Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation.
D'Anna R; Scilipoti A; Leonardi J; Scuderi M; Jasonni VM; Leonardi R
Clin Exp Obstet Gynecol; 1997; 24(3):135-7. PubMed ID: 9478297
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between anticardiolipin antibodies and fetal intrauterine growth retardation].
Wu J; Zeng W; Chen Z; Lu Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):62-4. PubMed ID: 11938744
[TBL] [Abstract][Full Text] [Related]
3. Anticardiolipin antibodies and the severity of preeclampsia-eclampsia.
Martínez-Abundis E; González-Ortiz M; Cortés-Llamas V; Salazar-Páramo M
Gynecol Obstet Invest; 1999; 48(3):168-71. PubMed ID: 10545739
[TBL] [Abstract][Full Text] [Related]
4. [Relation between fetal intrauterine growth retardation and anticardiolipin antibodies].
Wang Z; Fan Y; Wu G
Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):623-5. PubMed ID: 9642382
[TBL] [Abstract][Full Text] [Related]
5. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy.
Yasuda M; Takakuwa K; Tokunaga A; Tanaka K
Obstet Gynecol; 1995 Oct; 86(4 Pt 1):555-9. PubMed ID: 7675379
[TBL] [Abstract][Full Text] [Related]
6. beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women.
Katano K; Aoki A; Sasa H; Ogasawara M; Matsuura E; Yagami Y
Hum Reprod; 1996 Mar; 11(3):509-12. PubMed ID: 8671255
[TBL] [Abstract][Full Text] [Related]
7. [Antiphospholipid antibodies in high-risk pregnancy].
Nestorowicz B; Ostanek L; Ronin-Walknowska E; Fiedorowicz-Fabrycy I; Skoczowska M; Czajkowska E; Fischer K
Ginekol Pol; 2000 Jun; 71(6):500-8. PubMed ID: 11002552
[TBL] [Abstract][Full Text] [Related]
8. Measurement of antiphospholipid antibody by ELISA using purified beta 2-glycoprotein I in preeclampsia.
Yamamoto T; Yoshimura S; Geshi Y; Sasamori Y; Okinaga S; Kobayashi T; Mori H
Clin Exp Immunol; 1993 Oct; 94(1):196-200. PubMed ID: 8403506
[TBL] [Abstract][Full Text] [Related]
9. Poor pregnancy outcome and anticardiolipin antibodies.
De Carolis S; Caruso A; Ferrazzani S; Carducci B; De Santis L; Mancuso S
Fetal Diagn Ther; 1994; 9(5):296-9. PubMed ID: 7818777
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies in women at risk for preeclampsia.
Branch DW; Porter TF; Rittenhouse L; Caritis S; Sibai B; Hogg B; Lindheimer MD; Klebanoff M; MacPherson C; VanDorsten JP; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G;
Am J Obstet Gynecol; 2001 Apr; 184(5):825-32; discussion 832-4. PubMed ID: 11303189
[TBL] [Abstract][Full Text] [Related]
11. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin antibodies in pregnancy induced hypertension.
Uncu G; Ozan H; Küçükerdoğan I; Cengiz C
Eur J Obstet Gynecol Reprod Biol; 1996 Dec; 70(1):97-100. PubMed ID: 9031928
[TBL] [Abstract][Full Text] [Related]
13. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia.
Lee RM; Brown MA; Branch DW; Ward K; Silver RM
Obstet Gynecol; 2003 Aug; 102(2):294-300. PubMed ID: 12907102
[TBL] [Abstract][Full Text] [Related]
14. A prospective study on the occurrence of autoantibodies in low-risk pregnancies.
Matthiesen LS; Berg G; Ernerudh J; Skogh T
Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):21-6. PubMed ID: 10221605
[TBL] [Abstract][Full Text] [Related]
15. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in hypertensive disorders of pregnancy.
Valdés-Macho E; Cabiedes J; Villa AR; Cabral AR; Alarcón-Segovia D
Arch Med Res; 2002; 33(5):460-5. PubMed ID: 12459316
[TBL] [Abstract][Full Text] [Related]
16. Lupus anticoagulant and anticardiolipin antibodies in an obstetric population.
Rix P; Stentoft J; Aunsholt NA; Dueholm M; Tilma KA; Høier-Madsen M
Acta Obstet Gynecol Scand; 1992 Dec; 71(8):605-9. PubMed ID: 1336919
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
[TBL] [Abstract][Full Text] [Related]
18. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid syndrome characteristics and adverse pregnancy outcomes after 20 weeks of pregnancy.
Gabbay-Benziv R; Zafrir-Danieli H; Blickstein D; Shmueli A; Salman L; Hadar E
Int J Gynaecol Obstet; 2018 Aug; 142(2):214-220. PubMed ID: 29676461
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of various antiphospholipid antibodies in pregnant women.
Fialová L; Mikulíková L; Matous-Malbohan I; Benesová O; Zwinger A
Physiol Res; 2000; 49(3):299-305. PubMed ID: 11043916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
